Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

A prospective study of the risk of transfusion-acquired viral infections.

Murphy EL, Busch MP, Tong M, Cornett P, Vyas GN.

Transfus Med. 1998 Sep;8(3):173-8.

PMID:
9800288
3.

The current risk of retroviral infections transmitted by transfusion in patients who have undergone multiple transfusions. Cooleycare Cooperative Group.

Prati D, Capelli C, Rebulla P, Mozzi F, Bosoni P, De Mattei C, Sirchia G.

Arch Intern Med. 1998 Jul 27;158(14):1566-9.

PMID:
9679798
4.

Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection.

Asmuth DM, Kalish LA, Laycock ME, Murphy EL, Mohr BA, Lee TH, Gallarda J, Giachetti C, Dollard SC, van der Horst CM, Grant RM, Busch MP; Viral Activation Transfusion Study Group..

Transfusion. 2003 Apr;43(4):451-8.

PMID:
12662277
5.

Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.

Matee MI, Lyamuya EF, Mbena EC, Magessa PM, Sufi J, Marwa GJ, Mwasulama OJ, Mbwana J.

East Afr Med J. 1999 Mar;76(3):167-71.

PMID:
10442119
6.

Overview: diagnostic tests for viral infections transmitted by blood.

Holland PV.

Nucl Med Biol. 1994 Apr;21(3):407-17. Review.

PMID:
9234305
7.

Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.

Nelson KE, Donahue JG, Muñoz A, Cohen ND, Ness PM, Teague A, Stambolis VA, Yawn DH, Callicott B, McAllister H, et al.

Ann Intern Med. 1992 Oct 1;117(7):554-9.

PMID:
1524329
8.

Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.

O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC.

Transfusion. 2007 Feb;47(2):316-25.

PMID:
17302779
9.
11.

Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008.

Zou S, Musavi F, Notari EP, Stramer SL, Dodd RY.

Transfusion. 2010 Jul;50(7):1487-94. doi: 10.1111/j.1537-2995.2010.02621.x. Epub 2010 Mar 12.

PMID:
20345571
12.

Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial.

González A, Esteban JI, Madoz P, Viladomiu L, Genesca J, Muñiz E, Enríquez J, Torras X, Hernández JM, Quer J, et al.

Hepatology. 1995 Aug;22(2):439-45.

PMID:
7635410
13.

Epidemiology of transfusion-transmitted infections among multi-transfused patients in seven hospitals in Peru.

Laguna-Torres VA, Pérez-Bao J, Chauca G, Sovero M, Blichtein D, Chunga A, Flores W, Retamal A, Mendoza S, Cruz M, Monge Z, Lavalle M, Gutiérrez J, Málaga J, Soto E, Loayza N, Bolívar D, Reyna R, Mendoza C, Oré M, González J, Suárez M, Montano SM, Sánchez JL, Sateren W, Bautista CT, Olson JG, Xueref S.

J Clin Virol. 2005 Dec;34 Suppl 2:S61-8.

PMID:
16461242
14.

Tattooing and transfusion-transmitted diseases in Brazil: a hospital-based cross-sectional matched study.

de Nishioka SA, Gyorkos TW, Joseph L, Collet JP, MacLean JD.

Eur J Epidemiol. 2003;18(5):441-9.

PMID:
12889691
15.

Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.

Calderón GM, González-Velázquez F, González-Bonilla CR, Novelo-Garza B, Terrazas JJ, Martínez-Rodríguez ML, Cortés-Márquez SR, Blanco-Flores JP, Rodríguez-Rodríguez A, Del Campo MA, Cortés-Gómez R, Mejía-Bocanegra MG.

Transfusion. 2009 Oct;49(10):2200-7. doi: 10.1111/j.1537-2995.2009.02248.x. Epub 2009 Jun 15.

PMID:
19538543
16.

An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy.

Tosti ME, Solinas S, Prati D, Salvaneschi L, Manca M, Francesconi M, Ciuffreda M, Girelli G, Mele A.

Br J Haematol. 2002 Apr;117(1):215-9.

PMID:
11918558
17.

Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections.

Tani Y, Aso H, Matsukura H, Tadokoro K, Tamori A, Nishiguchi S, Yoshizawa H, Shibata H; JRC NAT Screening Research Group..

Vox Sang. 2012 May;102(4):285-93. doi: 10.1111/j.1423-0410.2011.01561.x. Epub 2011 Nov 14.

PMID:
22082342
18.

Post-transfusional anti-HCV-negative, non-A, non-B hepatitis. (I) a prospective clinical and epidemiological survey.

Azar N, Valla D, Lunel F, Fretz C, Mallet A, Jaulmes D, Fournel JJ, Blanc C, Perrin M, Amiel C, et al.

J Hepatol. 1993 Apr;18(1):24-33.

PMID:
7688012
19.

Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study (1995-1997).

Zervou EK, Boumba DS, Liaskos C, Georgiadou S, Tsianos EV, Dalekos GN.

Eur J Intern Med. 2003 Feb;14(1):39-44.

PMID:
12554009
20.

Supplemental Content

Support Center